An FDA Drug Voucher Program Needs a Reboot

Monday, July 10, 2017

Congress will be making changes to a priority review voucher program designed by Professors David Ridley and Jeffrey Moe to encourage drug development for neglected diseases. Ridley and Moe offer recommendations that they believe would better serve the people suffering from such diseases.